Novel drug combination nanoparticles exhibit enhanced plasma exposure and dose-responsive effects on eliminating breast cancer lung metastasis.
Early diagnosis along with new drugs targeted to cancer receptors and immunocheckpoints have improved breast cancer survival. However, full remission remains elusive for metastatic breast cancer due to dose-limiting toxicities of heavily used, highly potent drug combinations such as gemcitabine and...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Public Library of Science (PLoS)
2020
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/cb89d7d76ccd4535a410f364e5bbf9bc |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|